The DOI matches its Crossref record; 205 of the 209 references it cites were found in a registry or an index.
Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease
Open accessAbstract
Alzheimer disease (AD) and Parkinson disease (PD) are the two most common age-related neurodegenerative diseases characterized by prominent neurodegeneration in selective neural systems. Although a small fraction of AD and PD cases exhibit evidence of heritability, among which many genes have been identified, the majority are sporadic without known causes. Molecular mechanisms underlying neurodegeneration and pathogenesis of these diseases remain elusive. Convincing evidence demonstrates oxidative stress as a prominent feature in AD and PD and links oxidative stress to the development of neuronal death and neural dysfunction, which suggests a key pathogenic role for oxidative stress in both AD and PD. Notably, mitochondrial dysfunction is also a prominent feature in these diseases, which is likely to be of critical importance in the genesis and amplification of reactive oxygen species and the pathophysiology of these diseases. In this review, we focus on changes in mitochondrial DNA and mitochondrial dynamics, two aspects critical to the maintenance of mitochondrial homeostasis and function, in relationship with oxidative stress in the pathogenesis of AD and PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been proposed that ROS, which are considered markers of oxidative stress, are generated in the cytoplasm of neurons and can cause damage to key cellular components, including DNA, proteins, and lipids, leading to neuronal dysfunction and death (56, 59, 60).”
From Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4 (2014) · cites this paper as [60]
Experimental — accuracy not yet measuredIn the citing paper
“An increasing body of research indicates that ROS generation exacerbates α-synuclein misfolding in the brain, resulting in PD and other synaptic proteinopathies [37,38].”
From Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease (2022) · cites this paper as [37]
In the citing paper
“In clinical studies, probiotics have been shown to lower the development of α-synuclein aggregates by lowering ROS levels, thereby improving the condition of patients with PD [37,39].”
From Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease (2022) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A. A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M. J., Lincoln, S., Kachergus, J. M., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,087
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,854
Chen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E., & Chan, D. C. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211046 · Cited by 2,601
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán‐Ruiz, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munaín, A. L., Aparicio, S. F., Gil, A. M., Khan, N. L., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,453
Research works printed but not linked: 1
- Bonifati, 2003, Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism, Science, 299, 256, 10.1126/science.1077209 · DOI
Cited by
Sorted by citations
Items 701–720 of 720
Kharrati-Koopaee, H., Ebrahimie, E., Dadpasand, M., Niazi, A., Tian, R., & Esmailizadeh, A. (2021) · Figshare · doi:10.6084/m9.figshare.14936331
Kharrati-Koopaee, H., Ebrahimie, E., Dadpasand, M., Niazi, A., Tian, R., & Esmailizadeh, A. (2021) · Figshare · doi:10.6084/m9.figshare.14936334
Liang, T., Hang, W., Chen, J., Wu, Y., Wen, B., Xu, K., Ding, B., & Chen, J. (2021) · Figshare · doi:10.6084/m9.figshare.14175689
Additional file 1 of Identification of potential biomarkers for pathogenesis of Alzheimer’s disease
Wang, H., Han, X., & Gao, S. (2021) · Figshare · doi:10.6084/m9.figshare.14913749
Wang, Z., Zhang, Y., Xiu, Y., Chen, Z., Zhao, K., Yi, X., & Zhao, Z. (2026) · ACS Omega · doi:10.1021/acsomega.5c10585
Choi, J. Y., Thakuri, L. S., Song, S.-Y., Cho, S. S., & Rhyu, D. Y. (2026) · PharmaNutrition · doi:10.1016/j.phanu.2026.100482
SIRT1 Gen Polimorfizmleri ve Parkinson Hastalığı Arasındaki İlişkinin Araştırılması
Kuşcu, M., Demirel, E. A., Ermiş, E., & Çelik, S. (2020) · DergiPark (Istanbul University)
Khalil, B. (2016) · theses.fr (ABES) · doi:10.70675/4446111fz4182z4737zae76z7f117887a893
The role of mitochondria in the gut-kidney axis: implications for kidney health
Hu, Q., Jin, H., Hu, L., & Li, X. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1851705
A Quarter Century of EHD Protein Research: From Endosomal Recycling to Ciliopathies
Frisby, D., Misri, G., Naslavsky, N., & Caplan, S. (2026) · Traffic · doi:10.1111/tra.70039
Bai, Y., & Zhang, S. (2026) · Nutrition & Food Science · doi:10.1108/nfs-03-2026-0137
The Role of Cytochrome P450 Holoenzyme Metabolism in the Origin of Neuropathologies
Štambuk, S. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156971
Lee, S. H., Rho, Y., Lee, S., Shin, S., & Choi, Y. J. (2026) · Journal of Global Health · doi:10.7189/jogh.16.04187
The cGAS-STING Pathway: A Double-Edged Regulator of Neuroinflammation and Myelin Regeneration
Chen, X., Yu, X., Cao, X., Feng, J., Meng, Z., & Wang, X. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06174-3
Self-citationAlqahtani, S. M., Abdel‐Wahab, B. A., El‐Shoura, E. A. M., Kozman, M. R., Abdelzaher, L. A., Mahmoud, N. I., Selim, H. M., Gad, M. A., Mohamed, S. A., Rashwan, E. K., et al. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02387-z
Development and validation of an in vitro model to explore mechanisms of skeletal muscle toxicity
Dott, W. (2014) · Leicester Research Archive (University of Leicester)
Metadata
- Authors
- Yan, M. H., Wang, X., & Zhu, X.
- Affiliations
- Case Western Reserve University (US)
- Corresponding author
- Wang, Xinglong
- Zhu, Xiongwei
- Venue
- Free Radical Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 62
- Pages
- 90-101
- ISSN
- 0891-5849 (ISSN-L)
- PMC
- PMC3744189
- OpenAlex
- W2027783468
- Cited by
- 718
- References
- 209
- Citations by year
- 2026: 14 · 2025: 34 · 2024: 73 · 2023: 56 · 2022: 69 · 2021: 67 · 2020: 53 · 2019: 47 · 2018: 53 · 2017: 71 · 2016: 54 · 2015: 49 · 2014: 48 · 2013: 30
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Free Radical Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- the National Institutes of Health (AG031852, NS071184)
- Alzheimer's Association (IIRG-10–173358)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, Parkinson's disease, mitochondrial dysfunction, oxidative stress, mitochondrial DNA, mitochondrial dynamics, reactive oxygen species, neurodegeneration, mitochondrial homeostasis
- MeSH terms
- Alzheimer Disease, Humans, Mitochondria, Nerve Degeneration, Neurons, Parkinson Disease, Amyloid beta-Peptides, Cell Death, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
